- Home
- MNKD
MNKD
MannKind Corporation
as 02-21-2025 4:00pm EST
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Upcoming Earnings Alert:
Get ready for potential market movements as MannKind Corporation MNKD prepares to release earnings report on 26 Feb 2025.
| Founded: | 1991 | Country: | United States |
| Employees: | N/A | City: | DANBURY |
| Market Cap: | 1.5B | IPO Year: | 2004 |
| Target Price: | $8.92 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.47 - $7.63 | Next Earning Date: | 02-26-2025 |
| Revenue: | $267,200,000 | Revenue Growth: | 51.35% |
| Revenue Growth (this year): | 44.15% | Revenue Growth (next year): | 19.65% |
Latest MannKind Corporation News
MNKD Breaking Stock News: Dive into MNKD Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025
MT Newswires
12 days ago
Wedbush Initiates MannKind at Outperform With $11 Price Target
GlobeNewswire
15 days ago
MannKind to Present at Upcoming Investor Conferences
Simply Wall St.
20 days ago
MannKind Corporation's (NASDAQ:MNKD) institutional investors lost 4.0% over the past week but have profited from longer-term gains
GlobeNewswire
a month ago
MannKind Expands Executive Leadership Team
Insider Monkey
2 months ago
Here’s Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10
Simply Wall St.
2 months ago
Exploring 3 High Growth Tech Stocks In The United States
MT Newswires
2 months ago
MannKind Shares Rise After Wells Fargo Begins Coverage
Compare MNKD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MNKD MannKind Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.